kabutan

OncoTherapy Science, Inc., First Half Net Income Loss Narrows, July-September Net Income Loss Narrows

Fri Nov 8, 2024 5:00 pm JST Earnings

4564 OncoTherapy Science, Inc. 【J-GAAP】

Earnings Report

OncoTherapy Science, Inc. <4564> [TSE-G] announced its financial results after the market closed on November 8th (17:00). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 545 million yen (compared to a loss of 710 million yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated net loss improved to a deficit of loss of 243 million yen (compared to a loss of 310 million yen in the same period last year). However, the operating profit/loss margin drastically worsened from -148.1% in the same period last year to -192.8%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Sep, 2022 514 -618 -643 -613 -3.2 ー Nov 4, 2022 J-GAAP
Apr - Sep, 2023 356 -694 -708 -710 -3.4 ー Nov 10, 2023 J-GAAP
Apr - Sep, 2024 225 -531 -545 -545 -2.2 ー Nov 8, 2024 J-GAAP
YoY -36.8% +23.5% +23.0% +23.2% +36.3%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Guidance ー ー ー ー － － May 10, 2024 J-GAAP
Apr - Sep, 2024 Results 225 -531 -545 -545 -2.2 － Nov 8, 2024 J-GAAP
Revision Rate － － － － －

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2023 254 -426 -428 -578 -2.7 0 May 10, 2024 J-GAAP
Oct - Mar, 2024 Guidance ー ー ー ー － 0 May 10, 2024 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 1,134 -1,106 -1,133 -1,118 -5.8 0 May 12, 2023 J-GAAP
Mar, 2024 610 -1,120 -1,136 -1,288 -6.1 0 May 10, 2024 J-GAAP
Mar, 2025 Guidance ー ー ー ー － 0 May 10, 2024 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2023 208 -308 -311 -310 -1.5 -148.1 Nov 10, 2023 J-GAAP
Oct - Dec, 2023 110 -278 -278 -277 -1.3 -252.7 Feb 9, 2024 J-GAAP
Jan - Mar, 2024 144 -148 -150 -301 -1.4 -102.8 May 10, 2024 J-GAAP
Apr - Jun, 2024 100 -290 -302 -302 -1.3 -290.0 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 125 -241 -243 -243 -1.0 -192.8 Nov 8, 2024 J-GAAP
YoY -39.9% +21.8% +21.9% +21.6% +34.9%

Related Articles